Marijuana-Epilepsy Drug Cuts Seizures in Half

British drug maker GW Pharmaceuticals released the first results on the efficacy and safety of Epidiolex, a purified form of the marijuana compound cannabidiol (CBD), on Tuesday. The drug led to an average reduction in seizure frequency of 50% among a group of 27 children and young adults with treatment-resistant epilepsy.